KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) Shares Outstanding (Diluted Average) (2016 - 2025)

Eli Lilly's Shares Outstanding (Diluted Average) history spans 14 years, with the latest figure at $899.3 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) fell 0.53% year-over-year to $899.3 million; the TTM value through Dec 2025 reached $899.3 million, down 0.53%, while the annual FY2025 figure was $899.3 million, 0.53% down from the prior year.
  • Shares Outstanding (Diluted Average) reached $899.3 million in Q4 2025 per LLY's latest filing, roughly flat from $899.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $912.4 million in Q1 2021 to a low of $899.3 million in Q4 2025.
  • Average Shares Outstanding (Diluted Average) over 5 years is $904.7 million, with a median of $904.0 million recorded in 2024.
  • Peak YoY movement for Shares Outstanding (Diluted Average): decreased 0.79% in 2022, then rose 0.14% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $911.7 million in 2021, then fell by 0.77% to $904.6 million in 2022, then fell by 0.15% to $903.3 million in 2023, then increased by 0.09% to $904.1 million in 2024, then decreased by 0.53% to $899.3 million in 2025.
  • Per Business Quant, the three most recent readings for LLY's Shares Outstanding (Diluted Average) are $899.3 million (Q4 2025), $899.7 million (Q3 2025), and $899.8 million (Q2 2025).